Besselink Marc G H, Verwer Thomas J, Schoenmaeckers Ernst J P, Buskens Erik, Ridwan Ben U, Visser Maarten R, Nieuwenhuijs Vincent B, Gooszen Hein G
Department of Surgery, University Medical Center Utrecht, Room G.04.228, PO Box 85500, 3508 GA Utrecht, The Netherlands.
Arch Surg. 2007 Dec;142(12):1194-201. doi: 10.1001/archsurg.142.12.1194.
To determine the effect of timing of surgical intervention for necrotizing pancreatitis.
Retrospective study of 53 patients and a systematic review.
A tertiary referral center. Main Outcome Measure Mortality.
Median timing of the intervention was 28 days. Eighty-three percent of patients had infected necrosis and 55% had preoperative organ failure. The mortality rate was 36%. Sixteen patients were operated on within 14 days of initial admission, 11 patients from day 15 to 29, and 26 patients on day 30 or later. This latter group received preoperative antibiotics for a longer period (P < .001), and Candida species and antibiotic-resistant organisms were more often cultured from the pancreatic or peripancreatic necrosis in these patients (P = .02). The 30-day group also had the lowest mortality (8% vs 75% in the 1 to 14-days group and 45% in the 15 to 29-days group, P < .001); this difference persisted when outcome was stratified for preoperative organ failure. During the second half of the study, necrosectomy was further postponed (43 vs 20 days, P = .06) and mortality decreased (22% vs 47%, P = .09). We also reviewed 11 studies with a total of 1136 patients. Median surgical patient volume was 8.3 patients per year (range, 5.3-15.6), median timing of surgical intervention was 26 days (range, 3-31), and median mortality was 25% (range, 6%-56%). We observed a significant correlation between timing of intervention and mortality (R = - 0.603; 95% confidence interval, - 2.10 to - 0.02; P = .05).
Postponing necrosectomy until 30 days after initial hospital admission is associated with decreased mortality, prolonged use of antibiotics, and increased incidence of Candida species and antibiotic-resistant organisms.
确定坏死性胰腺炎手术干预时机的影响。
对53例患者进行回顾性研究并进行系统评价。
一家三级转诊中心。主要观察指标为死亡率。
干预的中位时间为28天。83%的患者发生感染性坏死,55%的患者术前出现器官功能衰竭。死亡率为36%。16例患者在初次入院后14天内接受手术,11例患者在第15至29天接受手术,26例患者在第30天或更晚接受手术。后一组患者术前使用抗生素的时间更长(P < .001),这些患者的胰腺或胰周坏死组织中更常培养出念珠菌属和耐药菌(P = .02)。30天组的死亡率也最低(8%,而1至14天组为75%,15至29天组为45%,P < .001);当根据术前器官功能衰竭对结果进行分层时,这种差异仍然存在。在研究的后半期,坏死组织清除术进一步推迟(43天对20天,P = .06),死亡率降低(22%对47%,P = .09)。我们还回顾了11项研究,共1136例患者。手术患者的年中位数量为8.3例(范围为5.3 - 15.6例),手术干预的中位时间为26天(范围为3 - 31天),中位死亡率为25%(范围为6% - 56%)。我们观察到干预时机与死亡率之间存在显著相关性(R = - 0.603;95%置信区间为 - 2.10至 - 0.02;P = .05)。
将坏死组织清除术推迟至初次入院后30天与死亡率降低、抗生素使用时间延长以及念珠菌属和耐药菌发生率增加相关。